Chrystal Paulos, Professor and Co-leader of the Cancer Immunology Program at Winship Cancer Institute of Emory University, shared a post on LinkedIn:
“It was a pleasure to hear Ignacio Melero open today’s BRIDGE Immunotherapy session with an excellent presentation on GDF-15 and its emerging relevance in immuno-oncology.
His clear overview of the biological mechanisms, clinical implications, and ongoing trials provided valuable insight into how this pathway may shape future therapeutic strategies.”
More posts featuring Ignacio Melero.
